Drawing for SECTRAL

USPTO serial 73074265

SECTRAL

Reviewed by CopyMark Law Group

Reg. 1061086Status 713
Filing date
Status date
Registration date
Mar 15, 1977
Examiner
Law office
TTAB

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SECTRAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005PHARMACEUTICAL PRODUCTS FOR HUMAN USE AND SPECIFICALLY, MEDICATION FOR THE TREATMENT OF CARDIO-VASCULAR DISEASESSECTION 18 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 9, 2021C18.CANCELLED SECTION 18-TOTAL
Sep 9, 2021CANTCANCELLATION TERMINATED NO. 999999
Aug 26, 2021CANGCANCELLATION GRANTED NO. 999999
Feb 11, 2021PETCCANCELLATION INSTITUTED NO. 999999
Jan 8, 2020CORVREVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Dec 10, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 19, 2017NA89NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Jun 19, 2017RNL3REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Jun 19, 201789AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Jun 19, 2017APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 2, 2017E89RTEAS SECTION 8 & 9 RECEIVED
Apr 5, 2017CORVREVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Jan 31, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 15, 2016REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Nov 8, 2007CFITCASE FILE IN TICRS
Apr 5, 2007RNL2REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Apr 5, 200789AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Apr 2, 2007PLGLASSIGNED TO PARALEGAL
Mar 6, 200789AFREGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
Mar 6, 2007E89RTEAS SECTION 8 & 9 RECEIVED
Aug 16, 2005TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
May 8, 1997RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Mar 17, 19979.AFREGISTERED - SEC. 9 FILED/CHECK RECORD FOR SEC. 8
Jan 25, 199115AKREGISTERED - SEC. 15 ACKNOWLEDGED
Jan 4, 1991RRPRRESPONSE RECEIVED TO POST REG. ACTION
Jan 4, 1991RRPRRESPONSE RECEIVED TO POST REG. ACTION
Dec 31, 1990PR15POST REGISTRATION ACTION MAILED - SEC. 15
Aug 2, 199015AFREGISTERED - SEC. 15 AFFIDAVIT FILED
Jul 6, 19828.OKREGISTERED - SEC. 8 (6-YR) ACCEPTEDThe USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline.

Frequently asked questions

Related guidance